These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 19947172)
1. Fluorofenidone inhibits TGF-beta1 induced CTGF via MAPK pathways in mouse mesangial cells. Wang L; Hu GY; Shen H; Peng ZZ; Ning WB; Tao LJ Pharmazie; 2009 Oct; 64(10):680-4. PubMed ID: 19947172 [TBL] [Abstract][Full Text] [Related]
2. KIOM-79 prevents S100b-induced TGF-beta1 and fibronectin expression in mouse mesangial cells. Jung DH; Kim YS; Kim JS J Ethnopharmacol; 2009 Sep; 125(3):374-9. PubMed ID: 19666101 [TBL] [Abstract][Full Text] [Related]
3. [Losartan inhibits high glucose-induced CTGF expression via ERK1/2 MAPK pathways in mouse mesangial cells]. Wang L; Tao LJ; Peng ZZ; Ning WB Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Jun; 25(6):486-9. PubMed ID: 19500499 [TBL] [Abstract][Full Text] [Related]
4. Doxycycline inhibits TGF-beta1-induced MMP-9 via Smad and MAPK pathways in human corneal epithelial cells. Kim HS; Luo L; Pflugfelder SC; Li DQ Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):840-8. PubMed ID: 15728539 [TBL] [Abstract][Full Text] [Related]
6. Connective tissue growth factor knockdown attenuated matrix protein production and vascular endothelial growth factor expression induced by transforming growth factor-beta1 in cultured human peritoneal mesothelial cells. Xiao L; Sun L; Liu FY; Peng YM; Duan SB Ther Apher Dial; 2010 Feb; 14(1):27-34. PubMed ID: 20438517 [TBL] [Abstract][Full Text] [Related]
7. Fluorofenidone attenuates collagen I and transforming growth factor-beta1 expression through a nicotinamide adenine dinucleotide phosphate oxidase-dependent way in NRK-52E cells. Peng ZZ; Hu GY; Shen H; Wang L; Ning WB; Xie YY; Wang NS; Li BX; Tang YT; Tao LJ Nephrology (Carlton); 2009 Sep; 14(6):565-72. PubMed ID: 19712256 [TBL] [Abstract][Full Text] [Related]
8. [p42/44 MAPK mediates synthesis of fractalkine by mesangial cells stimulated by connective tissue growth factor]. Wu SH; Lu C; Dong L; Zhou GP Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jan; 22(1):37-9. PubMed ID: 16388741 [TBL] [Abstract][Full Text] [Related]
9. Fluorofenidone suppresses epithelial-mesenchymal transition and the expression of connective tissue growth factor via inhibiting TGF-beta/Smads signaling in human proximal tubular epithelial cells. Yuan Q; Wang L; Zhang F; Wang R; Fu X; Peng Z; Ning W; Hu G; Wang Z; Tao L Pharmazie; 2011 Dec; 66(12):961-7. PubMed ID: 22312703 [TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta1 up-regulates the expression of nerve growth factor through mitogen-activated protein kinase signaling pathways in dental pulp cells. Yongchaitrakul T; Pavasant P Eur J Oral Sci; 2007 Feb; 115(1):57-63. PubMed ID: 17305717 [TBL] [Abstract][Full Text] [Related]
11. Fluorofenidone inhibits transforming growth factor-beta1-induced cardiac myofibroblast differentiation. Chen LX; Yang K; Sun M; Chen Q; Wang ZH; Hu GY; Tao LJ Pharmazie; 2012 May; 67(5):452-6. PubMed ID: 22764581 [TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways. Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969 [TBL] [Abstract][Full Text] [Related]
13. Effect of transforming growth factor-beta1 on expression of the connective tissue growth factor (CCN2/CTGF) gene in normal human gingival fibroblasts and periodontal ligament cells. Takeuchi H; Kubota S; Murakashi E; Fukada T; Hashimoto S; Takigawa M; Numabe Y J Periodontal Res; 2009 Apr; 44(2):161-9. PubMed ID: 19210343 [TBL] [Abstract][Full Text] [Related]
14. All-trans retinoic acid inhibits the increases in fibronectin and PAI-1 induced by TGF-beta1 and Ang II in rat mesangial cells. Liu X; Lü L; Tao BB; Zhu YC Acta Pharmacol Sin; 2008 Sep; 29(9):1035-41. PubMed ID: 18718172 [TBL] [Abstract][Full Text] [Related]
15. Phosphatidylinositol 3-kinase/Akt pathway is involved in transforming growth factor-beta1-induced phenotypic modulation of 10T1/2 cells to smooth muscle cells. Lien SC; Usami S; Chien S; Chiu JJ Cell Signal; 2006 Aug; 18(8):1270-8. PubMed ID: 16310342 [TBL] [Abstract][Full Text] [Related]
16. Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-beta1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells. Song CY; Kim BC; Lee HS Transl Res; 2008 Jan; 151(1):27-35. PubMed ID: 18061125 [TBL] [Abstract][Full Text] [Related]